Literature DB >> 19258259

MIRD commentary: proposed name for a dosimetry unit applicable to deterministic biological effects--the barendsen (Bd).

George Sgouros1, Roger W Howell, Wesley E Bolch, Darrell R Fisher.   

Abstract

The fundamental physical quantity for relating all biologic effects to radiation exposure is the absorbed dose, the energy imparted per unit mass of tissue. Absorbed dose is expressed in units of joules per kilogram (J/kg) and is given the special name gray (Gy). Exposure to ionizing radiation may cause both deterministic and stochastic biologic effects. To account for the relative effect per unit absorbed dose that has been observed for different types of radiation, the International Commission on Radiological Protection (ICRP) has established radiation weighting factors for stochastic effects. The product of absorbed dose in Gy and the radiation weighting factor is defined as the equivalent dose. Equivalent dose values are designated by a special named unit, the sievert (Sv). Unlike the situation for stochastic effects, no well-defined formalism and associated special named quantities have been widely adopted for deterministic effects. The therapeutic application of radionuclides and, specifically, alpha-particle emitters in nuclear medicine has brought to the forefront the need for a well-defined dosimetry formalism applicable to deterministic effects that is accompanied by corresponding special named quantities. This commentary reviews recent proposals related to this issue and concludes with a recommendation to establish a new named quantity.

Mesh:

Year:  2009        PMID: 19258259     DOI: 10.2967/jnumed.108.057398

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Radiation exposure, protection and risk from nuclear medicine procedures.

Authors:  Massimo Salvatori; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

Review 2.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

3.  The BJR and progress in radiobiological modelling.

Authors:  R G Dale
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

4.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

Review 5.  Modelling and dosimetry for alpha-particle therapy.

Authors:  George Sgouros; Robert F Hobbs; Hong Song
Journal:  Curr Radiopharm       Date:  2011-07

6.  Appropriate Use of Effective Dose in Radiation Protection and Risk Assessment.

Authors:  Darrell R Fisher; Frederic H Fahey
Journal:  Health Phys       Date:  2017-08       Impact factor: 1.316

7.  MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

Authors:  George Sgouros; John C Roeske; Michael R McDevitt; Stig Palm; Barry J Allen; Darrell R Fisher; A Bertrand Brill; Hong Song; Roger W Howell; Gamal Akabani; Wesley E Bolch; A Bertrand Brill; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels; Pat B Zanzonico
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

Review 8.  Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.

Authors:  George Sgouros
Journal:  Semin Nucl Med       Date:  2020-02-26       Impact factor: 4.446

9.  FZD10-targeted α-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model.

Authors:  Hitomi Sudo; Atsushi B Tsuji; Aya Sugyo; Yosuke Harada; Satoshi Nagayama; Toyomasa Katagiri; Yusuke Nakamura; Tatsuya Higashi
Journal:  Cancer Sci       Date:  2021-12-21       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.